News
Hosted on MSN1mon
Regeneron falls after appeals court ruling in Eylea case (update)in a patent case over Regeneron's blockbuster Eylea drug was affirmed by an appeals court. "We have considered Regeneron's remaining arguments and find them unpersuasive," the appeals court wrote ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results